These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18222157)

  • 21. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denmark decides not to introduce hepatitis B into the childhood vaccination programme.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.3. PubMed ID: 16794274
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal childhood hepatitis B vaccination: infants vs. preadolescents, the Canadian perspective.
    Scheifele D
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S35-7. PubMed ID: 9688098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal hepatitis B immunization. A policy challenge.
    Clay LS
    J Nurse Midwifery; 1993; 38(3):129-31. PubMed ID: 8331422
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 30. 24 year outcomes of hepatitis B vaccination in Hangzhou, China.
    Du J; Xu Y; Wang J; Liu S; Liu Y; Zhang X; Xu E
    Hum Vaccin Immunother; 2015; 11(8):2051-60. PubMed ID: 25714188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis B vaccination in France: vaccination coverage in 2002].
    Denis F
    Bull Acad Natl Med; 2004; 188(1):115-23. PubMed ID: 15368931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy.
    Karvonen T; Auranen K; Kuusi M; Leino T
    Vaccine; 2017 Jan; 35(3):412-418. PubMed ID: 28003042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union].
    Magdzik W
    Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001
    [No Abstract]   [Full Text] [Related]  

  • 37. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunoprophylaxis against hepatitis B].
    Mayoral Cortés JM; Fernández de la Mota E
    Med Clin (Barc); 1992 Nov; 99(16):624-6. PubMed ID: 1460928
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunization for hepatocellular carcinoma.
    Karthikeyan G
    Indian Pediatr; 1997 Dec; 34(12):1141-3. PubMed ID: 9715567
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.